abstract |
This invention broadly relates to recombinant DNA technology, molecular biology, neuroscience, and medicine.. Particularly, the present invention features novel sequences of the toxin and non-toxin components of the Clostridium botulinum toxin type A-Hall (Allergan) strain complex as well as the expression vector system in a heterologous organism and methods to express such nucleic acid sequences. |